Eczema Patients Have Lost Faith In Treatment: Survey
"); jQuery("#212 h3").html("

"); });
2022-09-13 HKT 20:53
A international survey has found that only 37 percent of eczema patients in the city are working on treatment plans with doctors, while two-thirds have lost hope.
GlobalSkin, an international alliance of dermatology patient organisations, initiated the study covering 330 eczema patients in the SAR, South Korea and Australia in August, with one-third of the respondents in Hong Kong.
Dermatologist Dr Johnny Chan said on Tuesday that the proportion of patients in the city seeking medical advice is “very low”.
He said more than 90 percent of them are being treated by public practitioners, but strained medical resources due to the Covid-19 pandemic have delayed their treatment.
“The queue time of every [eczema] treatment will be two to three years at the moment," he said, adding that does not taken into account the impact Covid has had on waiting times even longer.
“While they are waiting, they think the treatments will not be helping them, and may lose the faith in treatment. They think it’s just incurable, they don’t want to have any treatment anymore,” Chan said.
“Public doctors have a limited time to see a lot of patients every day."
But for moderate to severe cases, he said, "they need some more time for explanations about the disease nature: to have a more tailor-made treatment plan for the patients, and to explain any possible side effects and the way to avoid these side effects.”
Chan added that less than 10 percent of eczema sufferers had sought treatment from the private sector. He said high costs was "very much an issue" here, with 72 percent of patients saying the heavy financial burden had deterred them from visiting doctors.
Dr Marco Ho, who chairs the Hong Kong Allergy Association, said when treatment is delayed, a patients’ immune system further deregulates and their conditions worsen, hence their expectations in consultations can be over-optimistic.
“Sometimes you don’t have the best-matched medication treatment as well as therapies. They have a whole lot of ideas and their own personal belief, so end up when we say ‘control’, they say ‘cure’; when we say ‘short-term gain’, they want a ‘long-term' remission,” he said.
“At times we even think the patient needs hospitalisation [but] they can't afford to stop their work or school.”
To clear up such misinterpretations and handle mental problems when patients are suffering from skin conditions, the allergy association and a concern group under the Hong Kong Health Care Alliance launched a free online counseling service on Tuesday that will run for three months.
NTT Launches Financial AI Fabric Blueprint For Hong Kong FSIs
NTT Com Asia has released a service blueprint for its Financial AI Fabric in Hong Kong. The Financial AI Fabric bluepri... Read more
Asias Multi-Billion-Dollar Fraud Crisis: Can Fintechs Still Build Trust?
Digital financial services now shape everyday life, placing greater pressure on companies to earn and keep customer tru... Read more
Futu Launches AI Agent “Expert” Mode For Investment Analysis And Trade Support
Futu has launched a new AI-powered trading assistant that can assist with trade execution based on user instructions. T... Read more
DigiFT And SBI Launch Tokenised Japanese Equity Fund On Solana
DigiFT has partnered with SBI Global Asset Management to launch a tokenised Japanese high-dividend equity fund. The JX ... Read more
Baillie Gifford Launches Tokenised Bond Fund In Hong Kong
Baillie Gifford has launched its tokenised investment fund to professional investors in Hong Kong. The Baillie Gifford... Read more
SBI XDC Partners With DSRV To Explore Enterprise Solutions In Japan, South Korea
SBI XDC Network APAC has partnered with South Korean blockchain infrastructure firm DSRV to develop enterprise solution... Read more